BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10987049)

  • 1. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
    Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
    Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
    Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
    Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
    Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 6. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 9. Persister studies in leprosy patients after multi-drug treatment.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
    Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
    Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
    Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 16. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of viable organisms in leprosy patients treated with multidrug therapy.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Acta Leprol; 1999; 11(3):89-92. PubMed ID: 10544720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR.
    Williams DL; Gillis TP; Fiallo P; Job CK; Gelber RH; Hill C; Izumi S
    Mol Cell Probes; 1992 Oct; 6(5):401-10. PubMed ID: 1474978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.